De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Amrutanjan Health Care Toekomstige groei
Future criteriumcontroles 0/6
Momenteel beschikken we niet over voldoende analisten om de groei en omzet voor Amrutanjan Health Care te voorspellen.
Belangrijke informatie
n/a
Groei van de winst
n/a
Groei van de winst per aandeel
| Pharmaceuticals winstgroei | 18.0% |
| Inkomstengroei | n/a |
| Toekomstig rendement op eigen vermogen | n/a |
| Dekking van analisten | None |
| Laatst bijgewerkt | n/a |
Recente toekomstige groei-updates
Geen updates
Recent updates
Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60
Aug 31
Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60
Aug 17We Think You Should Be Aware Of Some Concerning Factors In Amrutanjan Health Care's (NSE:AMRUTANJAN) Earnings
May 31Pinning Down Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) P/E Is Difficult Right Now
May 03Amrutanjan Health Care (NSE:AMRUTANJAN) Has Affirmed Its Dividend Of ₹1.00
Feb 12Amrutanjan Health Care (NSE:AMRUTANJAN) Has Announced A Dividend Of ₹2.60
Sep 02Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60
Aug 19Amrutanjan Health Care (NSE:AMRUTANJAN) Is Due To Pay A Dividend Of ₹2.60
Aug 05Amrutanjan Health Care (NSE:AMRUTANJAN) Has Announced A Dividend Of ₹1.00
Feb 17Amrutanjan Health Care (NSE:AMRUTANJAN) Will Pay A Dividend Of ₹1.00
Nov 08Amrutanjan Health Care (NSE:AMRUTANJAN) Will Pay A Dividend Of ₹2.60
Aug 18Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Vies For A Place In Your Dividend Portfolio: Here's Why
Apr 30Should You Be Adding Amrutanjan Health Care (NSE:AMRUTANJAN) To Your Watchlist Today?
Apr 08Introducing Amrutanjan Health Care (NSE:AMRUTANJAN), The Stock That Zoomed 162% In The Last Five Years
Mar 11Trade Alert: The Non-Executive Independent Director Of Amrutanjan Health Care Limited (NSE:AMRUTANJAN), Govindan Raghavan, Has Just Spent ₹72k Buying A Few More Shares
Feb 24Is It Smart To Buy Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Before It Goes Ex-Dividend?
Feb 14Is Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) Latest Stock Performance A Reflection Of Its Financial Health?
Feb 12Is Amrutanjan Health Care Limited (NSE:AMRUTANJAN) A Smart Choice For Dividend Investors?
Jan 30
Is There More To The Story Than Amrutanjan Health Care's (NSE:AMRUTANJAN) Earnings Growth?
Jan 17Here's Why I Think Amrutanjan Health Care (NSE:AMRUTANJAN) Is An Interesting Stock
Jan 04What Type Of Shareholders Make Up Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) Share Registry?
Dec 22How Much is Amrutanjan Health Care's (NSE:AMRUTANJAN) CEO Getting Paid?
Dec 09If You Had Bought Amrutanjan Health Care (NSE:AMRUTANJAN) Stock Five Years Ago, You Could Pocket A 106% Gain Today
Nov 26Here's What We Like About Amrutanjan Health Care's (NSE:AMRUTANJAN) Upcoming Dividend
Nov 14Why Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Should Be In Your Dividend Portfolio
Oct 28Are Strong Financial Prospects The Force That Is Driving The Momentum In Amrutanjan Health Care Limited's NSE:AMRUTANJAN) Stock?
Oct 10I Ran A Stock Scan For Earnings Growth And Amrutanjan Health Care (NSE:AMRUTANJAN) Passed With Ease
Sep 22What Percentage Of Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Shares Do Insiders Own?
Sep 01With Amrutanjan Health Care Limited (NSE:AMRUTANJAN) It Looks Like You'll Get What You Pay For
Aug 11Have Insiders Been Selling Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Shares?
Jul 29In dit gedeelte presenteren we gewoonlijk prognoses voor de omzet- en winstgroei op basis van de consensusramingen van professionele analisten om beleggers te helpen begrijpen in hoeverre het bedrijf in staat is winst te genereren. Maar omdat Amrutanjan Health Care onvoldoende gegevens uit het verleden heeft verstrekt en geen analistenprognose heeft, kan de toekomstige winst niet betrouwbaar worden berekend door gegevens uit het verleden te extrapoleren of analistenprognoses te gebruiken.
Dit is een vrij zeldzame situatie, aangezien 97% van de bedrijven die worden gedekt door SimplyWall St wel financiële gegevens uit het verleden hebben.
Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 6/30/2024 | 4,271 | 426 | N/A | N/A | N/A |
| 3/31/2024 | 4,214 | 450 | 212 | 279 | N/A |
| 12/31/2023 | 3,946 | 440 | N/A | N/A | N/A |
| 9/30/2023 | 3,753 | 373 | 300 | 364 | N/A |
| 6/30/2023 | 3,865 | 432 | N/A | N/A | N/A |
| 3/31/2023 | 3,798 | 398 | 113 | 202 | N/A |
| 12/31/2022 | 3,860 | 418 | N/A | N/A | N/A |
| 9/30/2022 | 3,990 | 517 | 112 | 337 | N/A |
| 6/30/2022 | 3,986 | 588 | N/A | N/A | N/A |
| 3/31/2022 | 4,059 | 672 | 287 | 522 | N/A |
| 12/31/2021 | 3,935 | 627 | N/A | N/A | N/A |
| 9/30/2021 | 3,829 | 631 | 368 | 457 | N/A |
| 6/30/2021 | 3,644 | 668 | N/A | N/A | N/A |
| 3/31/2021 | 3,330 | 612 | 889 | 909 | N/A |
| 12/31/2020 | 2,984 | 589 | N/A | N/A | N/A |
| 9/30/2020 | 2,811 | 474 | 744 | 754 | N/A |
| 6/30/2020 | 2,635 | 322 | N/A | N/A | N/A |
| 3/31/2020 | 2,617 | 251 | 156 | 182 | N/A |
| 12/31/2019 | 2,876 | 314 | N/A | N/A | N/A |
| 9/30/2019 | 2,751 | 274 | N/A | N/A | N/A |
| 6/30/2019 | 2,621 | 257 | N/A | N/A | N/A |
| 3/31/2019 | 2,535 | 250 | 191 | 212 | N/A |
| 12/31/2018 | 2,406 | 158 | N/A | N/A | N/A |
| 9/30/2018 | 2,335 | 168 | N/A | N/A | N/A |
| 6/30/2018 | 2,288 | 201 | N/A | N/A | N/A |
| 3/31/2018 | 2,203 | 200 | N/A | 191 | N/A |
| 12/31/2017 | 2,247 | 165 | N/A | N/A | N/A |
| 3/31/2017 | 2,240 | 211 | N/A | N/A | N/A |
| 3/31/2016 | 1,867 | 206 | N/A | 207 | N/A |
| 3/31/2015 | 1,666 | 149 | N/A | 183 | N/A |
| 3/31/2014 | 1,417 | 124 | N/A | 174 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: Er zijn onvoldoende gegevens om te bepalen of de verwachte winstgroei van AMRUTANJAN boven de spaarquote ( 6.7% ) ligt.
Winst versus markt: Er zijn onvoldoende gegevens om te bepalen of de winst van AMRUTANJAN naar verwachting sneller zal groeien dan de markt Indian
Hoge groeiwinsten: Er zijn onvoldoende gegevens om te bepalen of de winst van AMRUTANJAN naar verwachting de komende 3 jaar aanzienlijk zal groeien.
Omzet versus markt: Er zijn onvoldoende gegevens om te bepalen of de omzet van AMRUTANJAN naar verwachting sneller zal groeien dan de markt Indian.
Hoge groei-inkomsten: Er zijn onvoldoende gegevens om te bepalen of de omzet van AMRUTANJAN naar verwachting sneller zal groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van AMRUTANJAN naar verwachting over 3 jaar hoog zal zijn